Neuronetics Inc. Company Profile
NASDAQ: STIMHealth CareMedical/Dental InstrumentsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 2.12 -0.93%
Neuronetics at a glance
Neuronetics Inc. (NASDAQ: STIM) is a Medical/Dental Instruments company in the Health Care sector headquartered in Malvern, PA. Neuronetics is led by Mr. Daniel L. Reuvers and employs about 658 people. The company's shares have traded publicly since 2018.
At a market capitalization of $165.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001227636, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Neuronetics do?
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Business description based on the company's public filings.
Company information
- Legal name
- Neuronetics Inc.
- Ticker
- NASDAQ: STIM
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Daniel L. Reuvers
- Employees
- 658
- Headquarters
- 3222 Phoenixville Pike, Malvern, PA, United States
- Phone
- 877 600 7555
- Website
- neurostar.com/neuronetics
- IPO year
- 2018
- Market cap
- $165.35M
- SEC CIK
- 0001227636
- Latest annual report
- 10-K · Mar 17, 2026
Companies similar to Neuronetics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| KRMDKORU Medical Systems Inc. | 3.00 | +0.67% | $137.80M | vs STIM |
| NYXHNyxoah SA | 1.35 | -4.93% | $137.48M | vs STIM |
| PDEXPro-Dex Inc. | 62.21 | -0.94% | $201.14M | vs STIM |
| KTWOK2 Capital Acquisition Corporation Class A | 10.07 | 0.00% | $201.81M | vs STIM |
| LUCDLucid Diagnostics Inc. | 0.6501 | +4.27% | $124.14M | vs STIM |
| QTEXQTREX Quantum Ltd. | 1.69 | +1.81% | $113.36M | vs STIM |
| PYPDPolyPid Ltd. | 4.90 | -1.01% | $99.53M | vs STIM |
| APYXApyx Medical Corporation | 2.36 | -7.45% | $99.41M | vs STIM |